Reporting Guidelines for Clinical Pharmacokinetic Studies: The ClinPK Statement

Salmaan Kanji; Meghan Hayes; Adam Ling; Larissa Shamseer; C. A. Chant; David J. Edwards; Scott Edwards; Mary H. H. Ensom; David R. Foster; Brian G. Hardy; Tyree H. Kiser; Charles la Porte; Jason A. Roberts; Rob Shulman; Scott E. Walker; Sheryl Zelenitsky; David Moher

doi:10.1007/s40262-015-0236-8

Back

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2009

Reporting genetic association studies: the STREGA statement

Erik von Elm, David Moher, Julian Little

Article2015

The REporting of Studies Conducted Using Observational Routinely-Collected Health Data (RECORD) Statement: Methods for Arriving at Consensus and Developing Reporting Guidelines

Stuart G. Nicholls, Pauline Quach, Erik von Elm, Astrid Guttmann, David Moher, Irene Petersen, Henrik Toft Sørensen, Liam Smeeth, Sinéad Langan, Eric I. Benchimol

Article2015

CONSORT 2010 Statement: Updated Guidelines for Reporting ParallelGroup Randomized Trials

Kenneth F. Schulz, Douglas G. Altman, David Moher

Article2010

Correspondence2010 Statement: updated guidelines for reporting parallel group randomised trials

Kenneth F. Schulz, Douglas G. Altman, David Moher

Article2014

CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials

Jun Suh Lee, Soyeon Ahn, Kyoung Ho Lee, Jee Hyun Kim, Kenneth F. Schulz, Douglas G. Altman, David Moher